MedTrace Logo

The Effects of L-arabinose on Intestinal Sucrase Activity in Man

NCT00302302 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2014-02-26

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of L-arabinose in a sugar-rich meal on intestinal sucrase activity in healthy volunteers by measuring postprandial blood glucose and insulin, and selected intestinal hormonal responses to increasing doses of L-arabinose.

Conditions

  • Blood Glucose

Interventions

DRUG

L-arabinose

Sponsors & Collaborators

  • Danisco

    collaborator INDUSTRY

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Klaus Bukhave, MSc, MScD · Institute of Human Nutrition, The Royal Veterinary and Agricultural University, Denmark

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2005-11-30
Completion
2006-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00302302 on ClinicalTrials.gov